Basic Information
ID: ALA816692
Type: Functional
Description: In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood
Format: BAO_0000221
Tissue: Blood
Target: Thromboxane A2 receptor(ALA2069)
Document: ALA1125965
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood: 1
Activity Charts
Bioactivity
Activity Types for Assay ALA816692
Kd
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 463.62 | 5.69 | 5.69 |
| 463.62 | 5.69 | 5.69 |
| 463.62 | 5.69 | 5.69 |
| 463.62 | 5.69 | 5.69 |
| 521.70 | 5.62 | 5.62 |
| 507.67 | 5.58 | 5.58 |
| 584.78 | 5.13 | 5.13 |
| 534.70 | 5.11 | 5.11 |
| 534.70 | 5.11 | 5.11 |
| 507.67 | 5.58 | 5.58 |
| 520.67 | 5.18 | 5.18 |
| 507.67 | 5.58 | 5.58 |
| 507.67 | 5.58 | 5.58 |
| 507.67 | 5.58 | 5.58 |
| 570.75 | 5.45 | 5.45 |
| 570.75 | 5.45 | 5.45 |
| 493.64 | 5.79 | 5.79 |
| 535.69 | 5.57 | 5.57 |
| 477.65 | 6.08 | 6.08 |
| 520.67 | 5.18 | 5.18 |
| 570.75 | 5.45 | 5.45 |
| 548.72 | 5.72 | 5.72 |
| 493.64 | 5.79 | 5.79 |
| 477.65 | 6.08 | 6.08 |
| 507.67 | 5.58 | 5.58 |
| 584.78 | 5.13 | 5.13 |
| 548.72 | 5.72 | 5.72 |
| 507.67 | 5.58 | 5.58 |